Research for new marker and target molecule in liver disease by peptidomics approach
Project/Area Number |
20590771
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Mie University |
Principal Investigator |
SHIRAKI Katsuya Mie University, 大学院・医学系研究科, 准教授 (90263003)
|
Co-Investigator(Kenkyū-buntansha) |
SUGIMOTO Kazushi 三重大学, 医学部附属病院, 助教 (60378370)
UCHIDA Kazuhiko 筑波大学, 人間総合科学研究科, 准教授 (90211078)
|
Project Period (FY) |
2008 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 肝疾患 / バイオマーカー / ペプチド / 糖鎖 / 肝癌 / プロテオミク / 肝炎 / プロテオミクス |
Research Abstract |
We have found many fragments of peptides that determine the severity of liver diseases. Among them, we identified and focused on the fragment of ITIH4. This peptide has specific sugar chains that change according to the liver disease status. This is very useful for the diagnosis of liver cirrhosis and hepatoma and the therapeutic strategy. This molecule would be the promising molecular target.
|
Report
(4 results)
Research Products
(31 results)
-
[Journal Article] Functional cell surface expression of Toll-like receptor 9 promotes cell proliferation and survival inhuman hepatocellular carcinomas.2010
Author(s)
Tanaka J, Sugimoto K, Shiraki K, Tameda M, Kusagawa S, Nojiri K, Beppu T, Yoneda K, Yamamoto N, Uchida K, Kojima T, Takei Y.
-
Journal Title
Int J Oncol. 37
Pages: 805-814
Related Report
Peer Reviewed
-
[Journal Article] Clinical significance of tumor markers in detection of recurrent hepatocellular carcinoma after radiofrequency ablation.2010
Author(s)
Beppu T, Sugimoto K, Shiraki K, Tameda M, Kusagawa S, Nojiri K, Tanaka J, Yamamoto N, Takei Y, Takaki H, Uraki J, Nakatsuka A, Yamakado K, Takeda K.
-
Journal Title
Int J Mol Med. 26
Pages: 425-433
NAID
Related Report
Peer Reviewed
-
[Journal Article] Classification of hypocholesterolemia lipid patterns using Chol/Trig Combination System.2010
Author(s)
Ooi K, Sugimoto K, Shiraki K, Yamamoto N, Tameda M, Beppu T, Tanaka J, Nojiri K, Kusagawa S, Takei Y, Masuda C, Nobori T.
-
Journal Title
Int J Mol Med. 25
Pages: 601-606
Related Report
Peer Reviewed
-
-
-
[Journal Article] Prospective study on the outcome of atients with hepatocellular carcinoma registered for living donor liver ransplantation : how long can they wait?2010
Author(s)
Mizuno S, Yokoi H, Shiraki K Usui M, Sakurai H, Tabata M, Sugimoto K, Takei, Yamakado K, Takeda K, Uemoto S, Isaji S.
-
Journal Title
Transplantation. 89
Pages: 650-654
Related Report
Peer Reviewed
-
-
-
-
-
-
-
[Journal Article] Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma : differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.2008
Author(s)
Yoneda K, Sugimoto K, Shiraki K, Tanaka J, Beppu T, Fuke H, Yamamoto N, Masuya M, Boric R, Uchida K, Takei Y.
-
Journal Title
Int J Oncol. 33
Pages: 929-936
Related Report
Peer Reviewed
-
[Journal Article] Protective role of interleukin-18 against Fas-mediated liver injury.2008
Author(s)
Yamamoto N, Murata K, Yoneda K, Fuke H, Yamaguchi Y, Ito K, Sugimoto K, Shiraki K, Yamanaka K, Mizutani H, Takei Y.
-
Journal Title
Int J Mol Med. 22
Pages: 43-48
Related Report
Peer Reviewed
-
[Journal Article] Early-stage hepatocellular carcinoma : radiofrequency ablation combined with chemoembolization versus hepatectomy.2008
Author(s)
Yamakado K, Nakatsuka A, Takaki H, Yokoi H, Usui M, Sakurai H, Isaji S, Shiraki K, Fuke H, Uemoto S, Takeda K.
-
Journal Title
Radiology. 247
Pages: 260-266
Related Report
Peer Reviewed
-
[Journal Article] Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization.2008
Author(s)
Fuke H, Sugimoto K, Shiraki K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Takaki H, Nakatsuka A, Yamakado K, Takeda K, Takei Y.
-
Journal Title
Aliment Pharmacol Ther 27
Pages: 1253-1260
Related Report
Peer Reviewed
-
[Journal Article] Up-regulation of Glypican-3 in Human Hepatocellular Carcinoma.
Author(s)
Suzuki M, Sugimoto K, Tanaka J, Tameda M, Inagaki Y, Kusagawa S, Nojiri K, Beppu T, Yoneda K, Yamamoto N, Ito M, Yoneda M, Uchida K, Takase K, Shiraki K.
-
Journal Title
Related Report
Peer Reviewed
-
[Journal Article] High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double deficient mice.
Author(s)
Beppu T, Gil-Bemabe P, Boveda-Ruiz D, D'Alessandro-Gabazza C, Matsuda Y, Toda M, Miyake Y, Shiraki K Murata M, Murata T, Yano Y, Morser J, Gabazza EC, Takei Y.
-
Journal Title
J Thromb Haemost. in press
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-